MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ: MSLE · HEALTHCARE · BIOTECHNOLOGY
$7.27
-4.47% today
Updated 2026-04-29
Market cap
$149.15M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$5 – $13
Volume
0.1M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$30.00
+312.65%
12-Month target
$6.19
-14.86%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-7.26M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-8.34M | $-11.98M | $-19.58M | $-24.87M | $-7.30M |
| EPS | — | — | — | — | $-1.70 |
| Free cash flow | $-4.26M | $-8.75M | $-17.41M | $-23.60M | $-7.26M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Satellos Bioscience Inc. Common Stock trades at $7.27. Our Smart Value Score of 16/100 indicates the stock is weak.
Frequently asked questions
What is Satellos Bioscience Inc. Common Stock's stock price?
Satellos Bioscience Inc. Common Stock (MSLE) trades at $7.27.
Is Satellos Bioscience Inc. Common Stock overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Satellos Bioscience Inc. Common Stock (MSLE)?
The analyst target price is $30.00, representing +312.7% upside from the current price of $7.27.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-66.40%
Beta1.08
50D MA$8.66
200D MA$7.04
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—